Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

417 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mechanisms of insulin resistance during acute endotoxemia.
Virkamäki A, Yki-Järvinen H. Virkamäki A, et al. Endocrinology. 1994 May;134(5):2072-8. doi: 10.1210/endo.134.5.8156907. Endocrinology. 1994. PMID: 8156907
Non-alcoholic fatty liver disease and risk of type 2 diabetes.
Lallukka S, Yki-Järvinen H. Lallukka S, et al. Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):385-95. doi: 10.1016/j.beem.2016.06.006. Epub 2016 Jun 23. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27432073 Review.
The fatty liver and insulin resistance.
Yki-Järvinen H, Westerbacka J. Yki-Järvinen H, et al. Curr Mol Med. 2005 May;5(3):287-95. doi: 10.2174/1566524053766031. Curr Mol Med. 2005. PMID: 15892648 Review.
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.
Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, Makkonen J, Taskinen MR, Oresic M, Yki-Järvinen H. Kotronen A, et al. Diabetologia. 2009 Apr;52(4):684-90. doi: 10.1007/s00125-009-1282-2. Epub 2009 Feb 13. Diabetologia. 2009. PMID: 19214471
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects.
Westerbacka J, Cornér A, Kannisto K, Kolak M, Makkonen J, Korsheninnikova E, Nyman T, Hamsten A, Fisher RM, Yki-Järvinen H. Westerbacka J, et al. Diabetologia. 2006 Jan;49(1):132-40. doi: 10.1007/s00125-005-0075-5. Epub 2005 Dec 16. Diabetologia. 2006. PMID: 16362280
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Diabetologia. 1997 Apr;40(4):454-62. doi: 10.1007/s001250050700. Diabetologia. 1997. PMID: 9112023
Combination therapies with insulin in type 2 diabetes.
Yki-Järvinen H. Yki-Järvinen H. Diabetes Care. 2001 Apr;24(4):758-67. doi: 10.2337/diacare.24.4.758. Diabetes Care. 2001. PMID: 11315844 Review. No abstract available.
Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.
Iozzo P, Lautamaki R, Geisler F, Virtanen KA, Oikonen V, Haaparanta M, Yki-Jarvinen H, Ferrannini E, Knuuti J, Nuutila P. Iozzo P, et al. Diabetologia. 2004 Jul;47(7):1149-1156. doi: 10.1007/s00125-004-1443-2. Epub 2004 Jul 9. Diabetologia. 2004. PMID: 15243703
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, Haaparanta M, Knuuti J, Nuutila P. Laine H, et al. J Clin Invest. 1998 Mar 1;101(5):1156-62. doi: 10.1172/JCI1065. J Clin Invest. 1998. PMID: 9486987 Free PMC article. Clinical Trial.
417 results
Jump to page
Feedback